Tang Jiaxin, Li Jing, Qin Shiyu, Xiao Yu, Liu Jiaxin, Chen Xian, Zhang Yunyuan
Department of Clinical Laboratory, The Affiliated Hospital of Qingdao University, Qingdao, China.
Department of Laboratory Science, Qingdao University, Qingdao, China.
Cancer Control. 2025 Jan-Dec;32:10732748251353077. doi: 10.1177/10732748251353077. Epub 2025 Jun 30.
The leucine-rich pentatricopeptide repeat-containing (LRPPRC) protein, a member of the pentatricopeptide repeat (PPR) family, is a mitochondria-associated protein that regulates various biological processes, including cell cycle progression and mitochondrial gene translation. LRPPRC has also been identified as an important causative gene in several mitochondrial diseases. N6-methyladenosine (m6A) is the most prevalent and extensive modification of mRNA in eukaryotes, playing a significant role in cellular proliferation, differentiation, and oncogenesis. As an m6A regulator, LRPPRC has been shown to play an important role in the development of various human metabolic diseases and malignant tumors. This review mainly focuses on summarizing the biological roles of LRPPRC in a variety of human malignant tumors, emphasizing the molecular mechanisms LRPPRC is involved in and its potential impact on tumor prognosis.
富含亮氨酸的五肽重复序列蛋白(LRPPRC)是五肽重复序列(PPR)家族的成员之一,是一种与线粒体相关的蛋白质,可调节包括细胞周期进程和线粒体基因翻译在内的各种生物学过程。LRPPRC也已被确定为几种线粒体疾病的重要致病基因。N6-甲基腺苷(m6A)是真核生物中mRNA最普遍、最广泛的修饰,在细胞增殖、分化和肿瘤发生中起重要作用。作为一种m6A调节剂,LRPPRC已被证明在各种人类代谢疾病和恶性肿瘤的发生发展中起重要作用。本综述主要侧重于总结LRPPRC在多种人类恶性肿瘤中的生物学作用,强调LRPPRC所涉及的分子机制及其对肿瘤预后的潜在影响。